| abstract |
It is intended to provide a preventive/a remedy, medicinal compositions and foods with health claims for inhibiting the onset and progress of liver cancer in humans and other animals. Namely, an inhibitor for liver caner onset and progress which contains, as the active ingredients, isoleucine, leucine and valine, in which the weight ratio of isoleucine, leucine and valine ranges from 1:1.5 to 2.5:0.8 to 1.7 and the daily administration dose of which is from 2.0 g to 50.0 g. |